High-tech medical device company names new CFO

Naples medical device company Catalyst OrthoScience, focused on the shoulder replacement orthopedics market, has named industry veteran Mark Quick CFO.

Quick joins Catalyst with nearly two decades of medical device experience, according to a statement. He was most recently at Orthofix Medical Inc., where he served in financial leadership and business development roles of increasing responsibility across financial planning and analysis, investor relations and mergers and acquisitions, the release states. 

Prior to Orthofix, he served as a sell-side equity research analyst covering the medical device industry at Canaccord Genuity. 

“I am thrilled to join (President and CEO Carl O'Connell) and the rest of the talented Catalyst team in their commitment, dedication, and focus to providing differentiated solutions to shoulder surgeons and patients,” Quick says in the release.

Catalyst recently received 510(k) clearance from the FDA to market its fully convertible stemmed total shoulder arthroplasty system with an ellipsoid anatomic head, the company says. This is the market’s first stemmed arthroplasty system featuring an ellipsoid humeral head, and expands the Catalyst portfolio to offer stemless, stemmed, and convertible shoulder replacement systems.

“Mark brings a wealth of expertise in the medical device market to our team, and we are excited to leverage his decades of experience as we continue to grow,” O’Connell says in the statement. “Our purposely designed approach to shoulder replacement surgery is focused squarely on solutions that better match the patient’s own anatomy, reduce complications and support the needs of surgeons for precision, accuracy and repeatability.”

Catalyst OrthoScience was founded in 2014 by orthopedic surgeon Dr. Steven Goldberg. Catalyst has a growing portfolio of patents and pending patents.